Denali Therapeutics (DNLI) Retained Earnings (2017 - 2026)
Denali Therapeutics' (DNLI) quarterly Retained Earnings came in at -$682000.0 in Q1 2026, down 100.02% year-on-year from $2.8 billion in Q1 2025, and down 200.0% on a QoQ basis from $682000.0 in Q4 2025.
Denali Therapeutics (DNLI) Retained Earnings (2017 - 2026) Analysis & Trends
Denali Therapeutics (DNLI) has 10 years of Retained Earnings data on file, last reported at -$682000.0 in Q1 2026.
- On a quarterly basis, Retained Earnings fell 100.02% year-over-year to -$682000.0 in Q1 2026; TTM through Mar 2026 was -$682000.0, a 100.02% decrease from a year earlier, with the FY2025 full-year figure at $682000.0, up 100.04% from the prior year.
- Retained Earnings for Q1 2026 stood at -$682000.0, down from $682000.0 in the prior quarter.
- Over the last five years, Retained Earnings for DNLI reached as high as $2.8 billion in Q1 2025 and fell as low as -$1.9 billion in Q3 2025.
- Historically, Retained Earnings has averaged -$430.0 million across 5 years, with a median of -$872.3 million in 2022.
- On a YoY basis, Retained Earnings climbed as much as 705203.45% in 2022 and fell as far as 167329.75% in 2022.
- Year by year, Retained Earnings stood at -$971.0 million in 2022, then dropped by 14.96% to -$1.1 billion in 2023, then sank by 37.88% to -$1.5 billion in 2024, then surged by 100.04% to $682000.0 in 2025, then slumped by 200.0% to -$682000.0 in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$682000.0 in Q1 2026, $682000.0 in Q4 2025, and -$1.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Denali Therapeutics | 4.37 Bn | 4.37 Bn | - | -682,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -682,000.00 |
| Dec 31, 2025 | 682,000.00 |
| Sep 30, 2025 | -1.92 Bn |
| Jun 30, 2025 | -1.80 Bn |
| Mar 31, 2025 | 2.79 Bn |
| Dec 31, 2024 | -1.54 Bn |
| Sep 30, 2024 | -1.42 Bn |
| Jun 30, 2024 | -2.66 Mn |
| Mar 31, 2024 | -1.30 Mn |
| Dec 31, 2023 | -1.12 Bn |
| Sep 30, 2023 | -996.74 Mn |
| Jun 30, 2023 | -1.44 Mn |
| Mar 31, 2023 | -1.08 Bn |
| Dec 31, 2022 | -970.99 Mn |
| Sep 30, 2022 | -872.31 Mn |
| Jun 30, 2022 | -12.27 Mn |
| Mar 31, 2022 | 1.64 Bn |
| Dec 31, 2021 | -645.00 Mn |
| Sep 30, 2021 | -521,000.00 |
| Jun 30, 2021 | 1.56 Bn |